title: Practical considerations for planning a therapeutic apheresis procedure.
abstract: The general medicine and critical care services often care for patients that require therapeutic apheresis. Apheresis procedures are performed for various hematologic, neurological, renal, autoimmune, metabolic, and other indications. To facilitate a prompt start to the procedure, the clinical team must coordinate efforts with several services, including those that perform the apheresis procedure, establish venous access, and provide blood or replacement products, in addition to the pharmacy and clinical laboratory. Some of these tasks are performed typically by the clinical teams, while others are performed typically by the apheresis team. Presented and discussed are the indications for therapeutic apheresis, calculations for the ordering of blood products, and several important and practical details to consider, thus preventing delays in starting the apheresis procedure.
authors.affiliation: Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. shelat@mail.med.upenn.edu
authors.forename: Suresh G
authors.initials: SG
authors.lastname: Shelat
mesh_terms: D001771:Blood Banks; D001781:Blood Component Removal / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods* / Q000592:standards; D002408:Catheters, Indwelling; D017707:Erythrocyte Transfusion / Q000009:adverse effects / Q000379:methods; D005112:Extracorporeal Circulation / Q000009:adverse effects / Q000379:methods; D006801:Humans; D007163:Immunosorbent Techniques; D033183:Interdisciplinary Communication; D007937:Leukapheresis / Q000379:methods; D008077:Lipoproteins, LDL / Q000097:blood; D010604:Pharmacy; D017893:Photopheresis / Q000009:adverse effects / Q000379:methods; D010820:Physicians; D010951:Plasma Exchange / Q000009:adverse effects / Q000379:methods; D010956:Plasmapheresis / Q000009:adverse effects / Q000379:methods; D010983:Plateletpheresis / Q000009:adverse effects / Q000379:methods
chemical_list: D008077:Lipoproteins, LDL